This model is speculative and requires further studies to: 1) validate the link between anti-PAD3/4 antibodies and ILD; and 2) determine if these antibodies can directly perpetuate lung damage in patients with RA. This evidence concerns the gene PADI3 and rheumatoid arthritis.